Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area

Sarah S. Lewis*, Becky A. Smith, Ibukunoluwa C. Akinboyo, Jessica Seidelman, Cameron Wolfe, Allan B. Kirk, Gavin Martin, Thomas Denny, Bruce Lobaugh, Catherine Rehder, Diana Cardona, Mark J. Lee, Christopher R. Polage, Michael B. Datto

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members.

Original languageEnglish
Pages (from-to)341-343
Number of pages3
JournalInfection Control and Hospital Epidemiology
Volume42
Issue number3
DOIs
StatePublished - Mar 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area'. Together they form a unique fingerprint.

Cite this